Europe Large Molecule Bioanalytical Testing Services Market Size, Share & Industry Trends Analysis Report By End-user (SMEs and Large Firms), By Test Type, By Type (ADA, Pharmacokinetics), By Phase, By Therapeutic Areas, By Country and Growth Forecast, 20
Description
Europe Large Molecule Bioanalytical Testing Services Market Size, Share & Industry Trends Analysis Report By End-user (SMEs and Large Firms), By Test Type, By Type (ADA, Pharmacokinetics), By Phase, By Therapeutic Areas, By Country and Growth Forecast, 2022 - 2028
The Europe Large Molecule Bioanalytical Testing Services Market would witness market growth of 9.4% CAGR during the forecast period (2022-2028).
By using specific laboratory investigations, validation entails proving that the method's performance characteristics are reliable and appropriate for the intended analytical applications. The criteria used it to validate the procedure are closely correlated to the acceptability of analytical findings.
It is widely recognized and known that the area of bioanalysis has grown to become an essential instrument in the process of finding and developing new drugs. Numerous assays, including those for significant metabolites, have been constantly created for NCEs over the past few decades to assist various phases of discovery and development. Additionally, a variety of analytical techniques are accessible for both generic and prescription medications.
Chronic diseases are the major cause of mortality and morbidity in Europe region, and research predicts that complicated conditions like diabetes & depression will impose an even higher burden in the future. Chronic disease is the leading cause of morbidity and mortality in Europe. A number of years ago, chronic diseases were thought of as an issue faced mostly by the wealthy and the older people. Today, people are aware that those of lower socioeconomic status, along with those of younger and middle-aged ages, are more likely to suffer from chronic diseases in countries with high incomes. The consequences for businesses are also very significant when such diseases occur.
The Germany market dominated the Europe Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $166.5 million by 2028. The UK market is exhibiting a CAGR of 8.5% during (2022 - 2028). Additionally, The France market would experience a CAGR of 10.2% during (2022 - 2028).
Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.
Scope of the Study
Market Segments covered in the Report:
By End-user
The Europe Large Molecule Bioanalytical Testing Services Market would witness market growth of 9.4% CAGR during the forecast period (2022-2028).
By using specific laboratory investigations, validation entails proving that the method's performance characteristics are reliable and appropriate for the intended analytical applications. The criteria used it to validate the procedure are closely correlated to the acceptability of analytical findings.
It is widely recognized and known that the area of bioanalysis has grown to become an essential instrument in the process of finding and developing new drugs. Numerous assays, including those for significant metabolites, have been constantly created for NCEs over the past few decades to assist various phases of discovery and development. Additionally, a variety of analytical techniques are accessible for both generic and prescription medications.
Chronic diseases are the major cause of mortality and morbidity in Europe region, and research predicts that complicated conditions like diabetes & depression will impose an even higher burden in the future. Chronic disease is the leading cause of morbidity and mortality in Europe. A number of years ago, chronic diseases were thought of as an issue faced mostly by the wealthy and the older people. Today, people are aware that those of lower socioeconomic status, along with those of younger and middle-aged ages, are more likely to suffer from chronic diseases in countries with high incomes. The consequences for businesses are also very significant when such diseases occur.
The Germany market dominated the Europe Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $166.5 million by 2028. The UK market is exhibiting a CAGR of 8.5% during (2022 - 2028). Additionally, The France market would experience a CAGR of 10.2% during (2022 - 2028).
Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.
Scope of the Study
Market Segments covered in the Report:
By End-user
- SMEs
- Large Firms
- Bioavailability
- ADME
- PD
- Bioequivalence
- Others
- ADA
- Pharmacokinetics
- Others
- Clinical
- Pre-clinical
- With Antibody
- Without Antibody (ELISA Based Assay)
- Oncology
- Neurology
- Infectious Diseases
- Cardiology
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Laboratory Corporation Of America Holdings
- IQVIA Holdings, Inc.
- Syneos Health, Inc.
- SGS S.A.
- Intertek Group PLC
- Pace Analytical Services, LLC
- ICON Plc
- Charles River Laboratories International, Inc.
- Thermo Fisher Scientific, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
122 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Large Molecule Bioanalytical Testing Services Market, by End-user
- 1.4.2 Europe Large Molecule Bioanalytical Testing Services Market, by Test Type
- 1.4.3 Europe Large Molecule Bioanalytical Testing Services Market, by Type
- 1.4.4 Europe Large Molecule Bioanalytical Testing Services Market, by Phase
- 1.4.5 Europe Large Molecule Bioanalytical Testing Services Market, by Therapeutic Areas
- 1.4.6 Europe Large Molecule Bioanalytical Testing Services Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Strategies deployed in Large Molecule Bioanalytical Testing Services Market
- Chapter 4. Europe Large Molecule Bioanalytical Testing Services Market by End-user
- 4.1 Europe SMEs Market by Country
- 4.2 Europe Large Firms Market by Country
- Chapter 5. Europe Large Molecule Bioanalytical Testing Services Market by Test Type
- 5.1 Europe Bioavailability Market by Country
- 5.2 Europe ADME Market by Country
- 5.3 Europe PD Market by Country
- 5.4 Europe Bioequivalence Market by Country
- 5.5 Europe Others Market by Country
- Chapter 6. Europe Large Molecule Bioanalytical Testing Services Market by Type
- 6.1 Europe ADA Market by Country
- 6.2 Europe Pharmacokinetics Market by Country
- 6.3 Europe Others Market by Country
- Chapter 7. Europe Large Molecule Bioanalytical Testing Services Market by Phase
- 7.1 Europe Clinical Market by Country
- 7.2 Europe Pre-clinical Market by Country
- 7.3 Europe Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 7.3.1 Europe With Antibody Market by Country
- 7.3.2 Europe Without Antibody (ELISA Based Assay) Market by Country
- Chapter 8. Europe Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- 8.1 Europe Oncology Market by Country
- 8.2 Europe Neurology Market by Country
- 8.3 Europe Infectious Diseases Market by Country
- 8.4 Europe Cardiology Market by Country
- 8.5 Europe Others Market by Country
- Chapter 9. Europe Large Molecule Bioanalytical Testing Services Market by Country
- 9.1 Germany Large Molecule Bioanalytical Testing Services Market
- 9.1.1 Germany Large Molecule Bioanalytical Testing Services Market by End-user
- 9.1.2 Germany Large Molecule Bioanalytical Testing Services Market by Test Type
- 9.1.3 Germany Large Molecule Bioanalytical Testing Services Market by Type
- 9.1.4 Germany Large Molecule Bioanalytical Testing Services Market by Phase
- 9.1.4.1 Germany Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 9.1.5 Germany Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- 9.2 UK Large Molecule Bioanalytical Testing Services Market
- 9.2.1 UK Large Molecule Bioanalytical Testing Services Market by End-user
- 9.2.2 UK Large Molecule Bioanalytical Testing Services Market by Test Type
- 9.2.3 UK Large Molecule Bioanalytical Testing Services Market by Type
- 9.2.4 UK Large Molecule Bioanalytical Testing Services Market by Phase
- 9.2.4.1 UK Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 9.2.5 UK Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- 9.3 France Large Molecule Bioanalytical Testing Services Market
- 9.3.1 France Large Molecule Bioanalytical Testing Services Market by End-user
- 9.3.2 France Large Molecule Bioanalytical Testing Services Market by Test Type
- 9.3.3 France Large Molecule Bioanalytical Testing Services Market by Type
- 9.3.4 France Large Molecule Bioanalytical Testing Services Market by Phase
- 9.3.4.1 France Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 9.3.5 France Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- 9.4 Russia Large Molecule Bioanalytical Testing Services Market
- 9.4.1 Russia Large Molecule Bioanalytical Testing Services Market by End-user
- 9.4.2 Russia Large Molecule Bioanalytical Testing Services Market by Test Type
- 9.4.3 Russia Large Molecule Bioanalytical Testing Services Market by Type
- 9.4.4 Russia Large Molecule Bioanalytical Testing Services Market by Phase
- 9.4.4.1 Russia Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 9.4.5 Russia Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- 9.5 Spain Large Molecule Bioanalytical Testing Services Market
- 9.5.1 Spain Large Molecule Bioanalytical Testing Services Market by End-user
- 9.5.2 Spain Large Molecule Bioanalytical Testing Services Market by Test Type
- 9.5.3 Spain Large Molecule Bioanalytical Testing Services Market by Type
- 9.5.4 Spain Large Molecule Bioanalytical Testing Services Market by Phase
- 9.5.4.1 Spain Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 9.5.5 Spain Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- 9.6 Italy Large Molecule Bioanalytical Testing Services Market
- 9.6.1 Italy Large Molecule Bioanalytical Testing Services Market by End-user
- 9.6.2 Italy Large Molecule Bioanalytical Testing Services Market by Test Type
- 9.6.3 Italy Large Molecule Bioanalytical Testing Services Market by Type
- 9.6.4 Italy Large Molecule Bioanalytical Testing Services Market by Phase
- 9.6.4.1 Italy Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 9.6.5 Italy Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- 9.7 Rest of Europe Large Molecule Bioanalytical Testing Services Market
- 9.7.1 Rest of Europe Large Molecule Bioanalytical Testing Services Market by End-user
- 9.7.2 Rest of Europe Large Molecule Bioanalytical Testing Services Market by Test Type
- 9.7.3 Rest of Europe Large Molecule Bioanalytical Testing Services Market by Type
- 9.7.4 Rest of Europe Large Molecule Bioanalytical Testing Services Market by Phase
- 9.7.4.1 Rest of Europe Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
- 9.7.5 Rest of Europe Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
- Chapter 10. Company Profiles
- 10.1 IQVIA Holdings, Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Recent strategies and developments:
- 10.1.4.1 Product Launches and Product Expansions:
- 10.1.4.2 Geographical Expansions:
- 10.2 SGS S.A.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Recent strategies and developments:
- 10.2.4.1 Geographical Expansions:
- 10.3 Intertek Group PLC
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.4 ICON plc
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Recent strategies and developments:
- 10.4.4.1 Acquisition and Mergers:
- 10.5 Charles River Laboratories International, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Recent strategies and developments:
- 10.5.4.1 Acquisition and Mergers:
- 10.6 Thermo Fisher Scientific, Inc.
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.7 Syneos Health, Inc.
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.8 Laboratory Corporation Of America Holdings
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Segmental and Regional Analysis
- 10.8.4 Recent strategies and developments:
- 10.8.4.1 Geographical Expansions:
- 10.9 Pace Analytical Services, LLC
- 10.9.1 Company Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
